Diamond Hill Capital Management Inc Gilead Sciences, Inc. Transaction History

Diamond Hill Capital Management Inc

$23.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $177 Million - $201 Million	-2,728,609 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $822,433 - $887,314	12,150 Added 0.45%	2,728,609 $191 Million
Q2 2021 Aug 03, 2021	BUY	$63.47 - $69.35 $5.7 Million - $6.23 Million	89,765 Added 3.42%	2,716,459 $187 Million
Q1 2021 May 04, 2021	BUY	$60.0 - $68.46 $15.1 Million - $17.2 Million	251,968 Added 10.61%	2,626,694 $170 Million
Q4 2020 Feb 08, 2021	BUY	$56.65 - $64.55 $682,122 - $777,246	12,041 Added 0.51%	2,374,726 $138 Million
Q3 2020 Nov 09, 2020	BUY	$62.1 - $78.08 $4.67 Million - $5.87 Million	75,172 Added 3.29%	2,362,685 $149 Million
Q2 2020 Aug 10, 2020	BUY	$72.34 - $84.0 $16 Million - $18.6 Million	221,244 Added 10.71%	2,287,513 $176 Million
Q1 2020 May 05, 2020	SELL	$62.63 - $80.22 $7.65 Million - $9.79 Million	-122,090 Reduced 5.58%	2,066,269 $154 Million
Q4 2019 Feb 07, 2020	BUY	$61.62 - $67.78 $7.57 Million - $8.33 Million	122,836 Added 5.95%	2,188,359 $142 Million
Q3 2019 Oct 30, 2019	BUY	$62.51 - $69.0 $5.81 Million - $6.41 Million	92,919 Added 4.71%	2,065,523 $131 Million
Q2 2019 Aug 01, 2019	BUY	$61.87 - $69.38 $6.61 Million - $7.42 Million	106,895 Added 5.73%	1,972,604 $133 Million
Q1 2019 Apr 30, 2019	BUY	$62.53 - $70.05 $6.57 Million - $7.36 Million	105,067 Added 5.97%	1,865,709 $121 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $428,441 - $559,083	7,077 Added 0.4%	1,760,642 $110 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $8.66 Million - $9.58 Million	121,423 Added 7.44%	1,753,565 $135 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $37.5 Million - $43.7 Million	577,590 Added 54.77%	1,632,142 $116 Million
Q1 2018 May 02, 2018	BUY	$72.84 - $88.8 $73.1 Million - $89.1 Million	1,003,610 Added 1970.1%	1,054,552 $79.5 Million
Q4 2017 Feb 06, 2018	BUY	$71.15 - $83.52 $3.62 Million - $4.25 Million	50,942	50,942 $3.65 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Diamond Hill Capital Management Inc with notifications on news.

Account